Literature DB >> 3557021

Survey of the AGA membership relating to patients with functional gastrointestinal disorders.

C M Mitchell, D A Drossman.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3557021     DOI： 10.1016/s0016-5085(87)91099-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  57 in total

Review 1.  Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Authors:  Laura Noddin; Michael Callahan; Brian E Lacy
Journal:  MedGenMed       Date:  2005-08-29

Review 2.  Evaluation of lower functional gut disorders.

Authors:  Christopher N Andrews; Martin Storr
Journal:  Can J Gastroenterol       Date:  2008-07       Impact factor: 3.522

3.  So-eum type as an independent risk factor for irritable bowel syndrome: a population-based study in Korea.

Authors:  Seung Ku Lee; Dae Wui Yoon; Hyeryeon Yi; Si Woo Lee; Jong Yeol Kim; Jin Kwan Kim; Jeong Hwa Hong; Chol Shin
Journal:  J Altern Complement Med       Date:  2014-08-22       Impact factor: 2.579

4.  Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients: a hospital-based Oriental study.

Authors:  C T Lee; T Y Chuang; C L Lu; C Y Chen; F Y Chang; S D Lee
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

5.  Which patients improve: characteristics increasing sensitivity to a supportive patient-practitioner relationship.

Authors:  Lisa Ann Conboy; Eric Macklin; John Kelley; Efi Kokkotou; Anthony Lembo; Ted Kaptchuk
Journal:  Soc Sci Med       Date:  2009-11-10       Impact factor: 4.634

6.  Food Intolerance: Dietary Treatments in Functional Bowel Disorders.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

7.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

8.  Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study.

Authors:  J R Mathias; M H Clench; V G Reeves-Darby; L M Fox; P H Hsu; P H Roberts; L L Smith; N J Stiglich
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

9.  Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate.

Authors:  J R Mathias; G S Baskin; V G Reeves-Darby; M H Clench; L L Smith; J H Calhoon
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

Review 10.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.